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Moloney murine leukemia virus causes thymic leukemias when injected into newborn mice. A major
determinant of the thymic disease specificity of Moloney virus genetically maps to the conserved viral core motif
in the Moloney virus enhancer. Point mutations introduced into the core site significantly shifted the disease
specificity of the Moloney virus from thymic leukemia to erythroid leukemia (N. A. Speck, B. Renjifo, E.
Golemis, T. N. Fredrickson, J. W. Hartley, and N. Hopkins, Genes Dev. 4:233-242, 1990). We previously
reported the purification of core-binding factors (CBF) from calf thymus nuclei (S. Wang and N. A. Speck,
Mol. Cell. Biol. 12:89-102, 1992). CBF binds to core sites in murine leukemia virus and T-cell receptor
enhancers. Affinity-purified CBF contains multiple polypeptides. In this study, we sequenced five tryptic
peptides from two of the bovine CBF proteins and isolated three cDNA clones from a mouse thymus cDNA
library encoding three of the tryptic peptides from the bovine proteins. The cDNA clones, which we call CBF
13 p22.0, CBF P p21.5, and CBF 1 p17.6, encode three highly related but distinct proteins with deduced
molecular sizes of 22.0, 21.5, and 17.6 kDa that appear to be translated from multiply spliced mRNAs
transcribed from the same gene. CBF 13 p22.0, CBF i8 p21.5, and CBF 13 p17.6 do not by themselves bind the
core site. However, CBF 13 p22.0 and CBF 13 p21.5 form a complex with DNA-binding CBF a subunits and as
a result decrease the rate of dissociation of the CBF protein-DNA complex. Association of the CBF 13 subunits
does not extend the phosphate contacts in the binding site. We propose that CBF 13 is a non-DNA-binding
subunit of CBF and does not contact DNA directly.

Core-binding factor (CBF), otherwise known as SL3-3
enhancer factor 1 (56), polyomavirus enhancer-binding factor 2 (PEBP2) (29, 49), and SL3 and AKV core-binding
factor (7), binds the conserved core site in mammalian type
C retroviral enhancers and the polyomavirus enhancer. CBF
also binds sites in the enhancers of several genes specifically
expressed in T cells, including the T-cell receptor (TCR)
chain genes (TCR-y, -8, and -1 [22, 42, 44, 60]) and the
immunoglobulin u-chain gene (60). Consensus CBF binding
sites have also been noted in the TCR CD3-E and CD3-8
genes and in the human tumor necrosis factor (x- and 1-chain
genes (54, 57).
Experiments from several laboratories identified the core
site as a T-cell-specific cis-acting sequence. It was first found
that mutations in the core site in Moloney and SL3-3 murine
leukemia virus (MLV) enhancers affected transcription from
these enhancers specifically in T cells (7, 53, 56). These core
site mutations also altered the pathogenic phenotypes of
Moloney and SL3-3 MLVs. A 2-bp mutation introduced into
both core sites in the Moloney MLV enhancer altered the
disease specificity of Moloney MLV from thymic leukemia
to erythroid leukemia (52), whereas a 3-bp mutation in all
four core sites in the SL3-3 MLV enhancer rendered SL3
MLV nonleukemogenic (20). Subsequently, several laboratories studying the TCR enhancers demonstrated that mutation of core sites in the TCR-y and -8 enhancers causes a large

decrease in transcription from these enhancers (5- to 20fold), thus identifying the core site as a critical cis-acting
element for transcription of the TCRy and -8 genes (22, 45).
Together, these studies suggest that the core-binding factors
contribute to the transcription of genes specifically expressed in T cells and that the thymotropic mammalian type
C retroviruses have coopted these proteins for the purpose
of viral gene expression.
We and others purified core-binding factors (CBF and
PEBP2) from calf thymus and c-Harvey-ras-transformed
mouse fibroblasts (29, 60). Affinity-purified CBF from both
sources consists of multiple polypeptides. Here we describe
the isolation of cDNA clones encoding several of the CBF
polypeptides from a mouse thymus cDNA library. These
cDNA clones encode non-DNA-binding subunits of CBF,
which we have named CBF m subunits. CBF m subunits
participate in the formation of a protein-DNA complex with
DNA-binding subunits of CBF which we call CBF a subunits. The association of CBF 1B decreases the rate of
dissociation of the CBF protein-DNA complex but does not
extend the phosphate contacts made by CBF a on the DNA.
We also present evidence suggesting that one of the CBF a
subunits is the product of a newly identified proto-oncogene
called the acute myeloid leukemia 1 (AML1) gene (39).
MATERIALS AND METHODS

Electrophoretic mobility shift assays. Complementary 18base oligonucleotides containing a high-affinity core site
deduced by Thornell et al. (57) (HA; 5'-GGATAT7TTiG
3TTAGCA-3'), wild-type core site from the Moloney MLV
enhancer (WT; 5'-GGATATCTGITGTAAGCA-3'), and
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mutant core site (MUT; 5'-GGATATCTiCCGiTAAGCA-3')
were synthesized, purified, and end labeled with [-y-32P]ATP
as described previously (60).
Competitor oligonucleotides were prepared by annealing
equal amounts of unlabeled complementary oligonucleotides
(27). The annealed oligonucleotides were used directly as
competitors in binding reactions. Binding reaction mixtures
contained 10,000 to 20,000 cpm (2 to 5 fmol) of 32P-endlabeled HA probe, binding buffer (10 mM Tris [pH 7.4], 1
mM 3-mercaptoethanol, 1 mM EDTA, 50 mM NaCl, 4%
glycerol) and 1 to 10 ,ul of protein sample in a total volume of
15 ,ul. To demonstrate the sequence specificity of the protein-DNA complex, an excess of unlabeled WT, HA, or
MUT oligonucleotide was included in some of the binding
reactions. After 15 min of incubation at room temperature
(RT) (unless otherwise indicated), the reaction mixtures
were fractionated by electrophoresis through 6% native
polyacrylamide gels in 0.5 x TBE buffer (22.5 mM Tris-HCI,
22.5 mM boric acid, 0.5 mM EDTA). Electrophoresis was
carried out at 130 V for 2 h at RT. Radioactivity was detected
by autoradiography of the dried gel.
Purification of CBF. CBF was purified from calf thymus
nuclear extracts as described previously (60), but the amount
of starting material and the column sizes were increased. All
buffers and reagents used in the scaled-up purification were
the same as those used in previous purifications (60) except
that the concentration of Nonidet P-40 in buffer Z was
reduced from 0.1% to 0.02%. Approximately 130 p,g of CBF
was purified from 10 g of crude nuclear extract by selective
pH denaturation, followed by chromatography on heparinSepharose columns (2.5 by 16 cm, 80 ml of resin), nonspecific double-stranded DNA-cellulose columns (2.5 by 7 cm,
34 ml of resin), and core oligonucleotide-coupled affinity
columns (1.5 by 2.3 cm, 4 ml of the HA resin). Fifty-milliliter
aliquots of fractions from the DNA-cellulose column with
core-binding activity were passed four times successively
over the HA column, and the fractions eluted with 1 M NaCl
were collected and pooled. The total volume obtained after
the fourth passage through the HA affinity column was
approximately 35 ml.
Amino acid sequence determination. Five milliliters of
purified CBF was precipitated with 9.1% trichloroacetic acid
in the presence of 0.14 mg of deoxycholate per ml as carrier.
After incubation on ice for 45 min, the samples were pelleted
by microcentrifugation at 16,000 x g for 15 min at 4°C. The
pellet was resuspended in 100 p,l of sample buffer (20 mM
dithiothreitol [DTT], 92.5 mM Tris-HCl [pH 6.8], 10% glycerol, 2% sodium dodecyl sulfate [SDS], 2.5 mM EDTA,
0.004% bromophenol blue), the pH of the sample was
adjusted to neutrality with 2 M Tris base, and the sample was
boiled and electrophoresed through an SDS-15% polyacrylamide gel (15 by 15 cm, 1.0 mm thick) (33) along with
low-molecular-weight protein standards (Bio-Rad). Electrophoresis was conducted at constant current of 25 mA for
about 5 to 6 h.
Proteins were electrophoretically transferred from the gel
to a nitrocellulose membrane (0.45-mm pore size; Schleicher
& Schuell) in Tris-glycine transfer buffer (190 mM glycine,
25 mM Tris) at 70 to 75 V (0.8 to 1.4 A) at 4°C for 70 to 120
min. Following transfer, proteins on the membrane were
stained with Ponceau S, using a modification of the method
described by Salinovich and Montelaro (47). The nitrocellulose membrane was immersed for 1 to 2 min in a solution
containing 0.2% Ponceau S dye (FisherBiotech) in 1% aqueous acetic acid. Excess stain was removed from the membrane by gentle agitation for 60 to 90 s in 1% aqueous acetic
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acid. Protein bands detected by Ponceau S staining were
excised and transferred to Eppendorf tubes. The membranebound proteins were briefly destained with 0.2 M NaOH for
1 to 2 min and washed with distilled water. Two membranebound CBF polypeptides of 24 and 19 kDa were used for
amino acid analysis. In situ tryptic digests and amino acid
sequence determination were performed by William Lane at
the Harvard Microchemistry Facility.
PCR amplification of a 50-bp sequence encoding peptide 3/5.
A DNA fragment encoding the central portion of tryptic
peptide 3/5 from p24 and p19 CBF (see Fig. 3 for peptide
sequences) was amplified by polymerase chain reaction
(PCR) from mouse thymus cDNA (11, 35). Primer SW1
(Operon Technology) was designed from the amino acid
sequence near the N terminus of peptide 3/5, Glu-Ile-AlaPhe-Val. The base corresponding to the third position in the
codon for the fifth amino acid (Val) was omitted to reduce
the degeneracy of the primer by twofold. An additional eight
bases which included the recognition site for BamHI were
added to the 5' end, giving rise to primer SW1, containing 22
nucleotides with a degeneracy of 48-fold. Sequences of the
primers are as follows:
SW1 5'-C(GgATOOGARATHGCNTTYGT-3' degeneracy, 48; Tm = 61.6°C
BamHI
SW2A 5'-CG2AA=TTGYTCNCCYTGCCA-3' degeneracy, 16; Tm = 60.8'C
EcoRI
[GI
SW2B 5'-CGQAATTGTGYTCYTGYTGOCCA-3' degeneracy, 8; Tm = 58.8°C
(Q)

EcoRI

SW3A 5'-CARTTYTCCNGCNTCNTGGCA-3' degeneracy, 512; Tm = 64
SW3B 5'-CARTTYTTYCCNGCNAGYTGGCA-3' degeneracy, 256; Tm = 64

The antisense primer (primer SW2A or SW2B) was designed from five amino acids at the 3' end of peptide 3/5
(Trp-Gln-Gly/Gln-Glu-Gln). Two separate primers were designed because of the ambiguity at amino acid 25 (Gly and
Gln). SW2A is 16-fold degenerate and encodes the amino
acid Gly at position 25. SW2B is eightfold degenerate, and
encodes Gln at position 25. Both the SW2A and SW2B
primers contain a restriction site for EcoRI at the 5' end.
Again, the base corresponding to the third position in the
codon for the fifth amino acid (Gln) was omitted to decrease
the degeneracy of the primers by twofold.
Twenty-three-base oligonucleotides were designed from
the amino acid sequence in the middle of peptide 3/5,
Gln-Phe-Phe-Pro-Ala-Ser-Trp-Gln, to use as probes in colony hybridizations. Because of the high degeneracy of Ser,
two separate pools of degenerate oligonucleotides were
designed to reduce the total degeneracy to 768. SW3A was
designed from four possible codons of Ser, and SW3B was
designed from the remaining Ser codons. SW3A is twofold
more degenerate than SW3B; therefore, SW3A and SW3B
were combined in a 2:1 molar ratio and used as probes to
screen for specific PCR products.
Lambda phage DNA isolated from a liquid phage lysate
(34) of a mouse thymus XZAP cDNA library (Stratagene)
was used as the template for PCR amplification. Two rounds
of PCR were conducted to amplify a unique nucleotide
sequence encoding the middle portion of peptide 3/5. The
PCR mixture contained 1 ,ug of XZAP cDNA, 250 pmol each
of SW1 plus SW2A or SW1 plus SW2B, and 0.2 mM each
deoxynucleoside triphosphate, in reaction buffer (10 mM
Tris-HCl, 50 mM KCl, 1.5 mM MgCI2, 0.001% [wt/vol]
gelatin), and 1.25 U of Taq DNA polymerase, in a total
volume of 50 p,l. All the reagents used for PCR were supplied
in the GeneAmp DNA amplification reagent kit (PerkinElmer/Cetus). After the initial denaturation at 94°C for 4
min, the reaction mixtures were incubated at 94°C for 1 min
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and 37°C for 2 min for 5 cycles, at 94°C for 1 min and Tm 15°C for 2 min for 25 cycles, and then for 7 min at 72°C. Tm
- 15°C is 46 and 43°C for reactions containing SW2A and
SW2B, respectively.
PCR products from the first amplification were electrophoresed through a 4% low-melting-point agarose gel, and a
gel slice corresponding to the expected size of 88 bp was
excised from the gel. PCR products recovered from the gel
slice were used as templates for a second round of PCR
(94°C for 4 min; 94°C for 1 min and Tm - 15°C for 2 min for
30 cycles; 72°C for 7 min). A PCR product of the expected
size (88 bp) was easily detectable on an ethidium bromidestained 4% agarose gel.
The PCR-amplified DNA fragments were digested with
BamHI and EcoRI, isolated from 4% low-melting-point
agarose gels, and subcloned into the pBluescript SK+ vector
in the BamHI and EcoRI sites. Eschenichia coli MM294 was
transformed with ligation mixtures, and colonies were
screened by colony hybridization using the 32P-end-labeled
oligonucleotides SW3A and SW3B. DNA-bound nitrocellulose filters were prehybridized at 39°C (Tm- 25°C) for 4 h in
6x SSC (lx SSC is 0.15 M NaCl plus 0.015 M sodium
citrate)-5x Denhardt's solution-0.05% sodium pyrophosphate-0.1% SDS-0.1 mg of salmon sperm DNA per ml and
then hybridized with 1 x 106 to 2 x 106 cpm of 32P-endlabeled SW3A and SW3B per ml in the same buffer for 20 h
at 39°C. The filters were then washed four times in 2 x
SSC-0.1% SDS for 15 min each time at RT and once for 15
min at 44°C (Tm - 20°C). Following autoradiography of the
washed filters, putative positive clones were sequenced. A
50-bp sequence encoding the amino acids between the
primers was identified in several subclones obtained by using
primers SW1 and SW2A.
Isolation of CBF 13 cDNA clones. Two 25-base oligonucleotides, SWll (5'-GTGGCTACAGGAACCAATCTGTCTC3') and SW12 (5'-TCCAG'1'T'lTl'lTCCGGCCAGCTGGCA3') (Macromolecular Resources, Colorado State University),
were designed from each end of the 50-bp sequence encoding
the middle portion of peptide 3/5 and used to screen the
mouse thymus XZAP cDNA library. Duplicate filters (one
set of filters for each oligonucleotide probe) were hybridized
for 48 h at 42°C in 6x SSC-5x Denhardt's solution-0.1%
SDS-0.05% sodium pyrophosphate-0.1 mg of salmon sperm
DNA per ml-105 cpm of 32P-end-labeled SWll or SW12
oligonucleotide probe per ml. The filters were washed four
times at RT with 6x SSC-0.1% SDS and exposed overnight.
One positive phage was isolated from screening 5.6 x 105
phage. In vivo excision of the phagemid containing the insert
was performed as instructed by the manufacturer (Stratagene). The 1.4-kb insert from the phagemid was excised with
EcoRI, labeled by random priming (14, 15), and used as a
probe to rescreen the mouse thymus cDNA library. Eleven
independent clones were isolated and purified.
The CBF cDNA clones were sequenced by sequential
oligonucleotide mapping along the cDNA inserts in both
directions, using the dideoxy-chain termination method (48).
All reagents were provided in a Sequenase version 2.0 kit
(U.S. Biochemical). Sequences of the cDNA clones were
read and input into the computer by using the DNA Parrot
program and analyzed by DNA Strider and the Genetics
Computer Group package of the University of Wisconsin.
Preparation of CBF 13-GST fusion proteins. DNA fragments containing the open reading frames of CBF 1 p22.0,
CBF ,B p21.5, and CBF 13 p17.6 were subcloned into the
glutathione S-transferase (GST) fusion vector pGEX2T
(Pharmacia) for the purpose of expressing CBF ,B-GST
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fusion proteins. Two PCR primers hybridizing to positions
82 to 102 of CBF 13 p21.5 (5'-AGACGGATCCATGiCCGC
GCGTCGTCCCGGAC-3', starting at the ATG translation
start codon [underlined] and including a BamHI site at the 5'
end of the primer) and positions 688 to 703 (5'AGAGATGGGGCACATAAG-3') were used to amplify a
603-bp fragment. The PCR-amplified fragment was subsequently digested with BamHI and at an internal HaeII site
(position 201 of CBF 13 p21.5), yielding a 125-bp fragment
which contains sequences common to all three CBF 13 cDNA
clones. This PCR-amplified 125-bp DNA fragment was subcloned along with a HaeII-PstI fragment from each of the
CBF 1 clones (corresponding to nucleotides 202 to 777 of
CBF 1 p21.5) into the BamHI and PstI sites in the polylinker
of pBluescript SK+. The correct sequence of the PCRamplified region was confirmed by dideoxy sequencing from
the T3 primer. The CBF 13 inserts were then excised from the
pBluescript SK+ phagemid with BamHI and EcoRI and
subcloned into the BamHI-EcoRI sites of pGEX2T. The
CBF 1-GST fusion proteins were expressed in E. coli
MM294 and purified on glutathione-agarose beads (51).
Recovery of DNA-binding CBF a subunits from SDSpolyacrylamide gels. DNA-binding CBF a subunits were
isolated from affinity-purified bovine CBF (19, 60). One
milliliter of purified bovine CBF was trichloroacetic acid
precipitated and fractionated through an SDS-15% polyacrylamide gel. The gel was stained with Coomassie brilliant
blue, the visible polypeptides were excised from the gel, and
the gel slices were chopped into small pieces. Proteins were
eluted by incubating the gel slice in 200 to 300 Rl of a buffer
containing 150 mM NaCl, 20 mM N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid (HEPES; pH 7.5), 5 mM DTT,
0.1 mM EDTA, 0.1% SDS, and 0.1 mg of bovine serum
albumin (BSA) per ml overnight at RT. The eluted proteins
were precipitated with 4 volumes of cold (-20°C) acetone.
Following incubation for 45 min in a dry ice-ethanol bath,
proteins were pelleted by microcentrifugation at 16,000 x g
for 30 min. The pellets were washed with a solution containing 80% acetone, 20% dilution buffer (150 mM NaCl, 20 mM
HEPES [pH 7.5], 1 mM DTT, 0.1 mM EDTA, 20% glycerol),
dried, dissolved in 5 to 10 ,ul of dilution buffer supplemented
with 6 M guanidine-HCl, and incubated at RT for 30 min.
The proteins were renatured by diluting the sample 1:50 with
dilution buffer and incubating it for 2 h at RT. The protein
samples were then assayed for core-binding activity by
electrophoretic mobility shift assay. Protein samples that
yielded only one protein-DNA complex and were thus
judged to be free from contamination by CBF 1 subunits
were used in subsequent analyses.
DNase I footprinting analysis. Probes from the top and
bottom strands of the TCR-y enhancer probe were prepared
from plasmid J21-.20RR (54), kindly provided by David
Raulet. J21-.20RR contains a 196-bp RsaI-RsaI fragment
from the TCRy enhancer subcloned into the polylinker of
plasmid J21 (61). The plasmid was labeled at the XhoI or
ClaI site in the polylinker of J21 as described previously (60).
DNase I footprinting was conducted exactly as previously
described (60).
Measurement of dissociation rate constants. The rate of
dissociation of CBF ax and CBF a+ 13 subunits was measured
by using electrophoretic mobility shift assays. A fixed
amount of the CBF a and CBF a plus CBF 1-GST fusion
protein (approximately 10' M CBF a and 10-6 M CBF 1
p21.5-GST) was incubated with a saturating amount of the
HA probe (75-,ul total volume per binding reaction) at RT for
20 min and then on ice for 15 min. Binding reactions were
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also performed with bovine CBF polypeptides renatured
from SDS-polyacrylamide
gels that contained both CBF ao
,B
and CBF subunits (polypeptide bands F to M; see Fig. 5).
A
aliquot of the binding reaction was loaded onto a
running native polyacrylamide gel. A 50-fold molar excess of
unlabeled HA binding site was then added to the remainder
of the binding reaction to trap the dissociated CBF proteins,
and
aliquots were removed at defined intervals (15, 30,
60, and 300 s) and loaded onto the running gel. Electrophoresis was conducted at 4°C. Following autoradiography of the
dried gel, the autoradiogram was photographed, scanned,
and quantified with the National Institutes of Health Image
1.44 program (36). The rate constant for dissociation was
calculated from the slope of the plot of log(% bound at each
time - % bound at t =m0)(x0 300 s) versus time.
Ethylation interference analysis. The probes used in the
ethylation interference analysis were 37-bp oligonucleotides
containing a core site from the TCR5 enhancer (5E3, kind
gift from Mike Krangel):
5'-CTAGAAGCAATGCATGTGGTTTCCAACCGTTAATGCTAGAG-3'
3'-TTCGTTACGTACACAAAGGTTGGCAATTACGATCTCCTAG-5'
Double-stranded probes 32P end labeled on either the top or
bottom strand were modified on phosphates with N-ethyl-Nnitrosourea (Sigma) prior to use in binding reactions, as
described by Siebenlist and Gilbert (50). The binding reactotal volume) contained 100,000 cpm of endtion
labeled probe and either 20pl of bovine CBF a subunit or 20
,ug) of CBF p21.5-GST protein
of CBF at plus 5pl (12.5
in the same buffer used for electrophoretic mobility shift
assays. The binding reaction was electrophoresed through a
6% native polyacrylamide gel. Following overnight exposure
of the wet gel, the bands corresponding to the CBF and
CBF oa+1 protein-DNA complexes and free DNA bands
were excised from the gel, electroeluted onto a NA45
membrane (Schleicher & Schuell), and eluted from the
membrane in elution buffer (20 mM Tris-HCI [pH 8.0], 0.1
at
for 1 h (5). The DNA was
mM EDTA, 1.0 M NaCl) 68°C
then extracted once each with phenol and chloroform,
recovered by ethanol precipitation, and subjected to alkali
cleavage (50). Free 2P-labeled single-stranded probe was
also subjected to alkali cleavage. Equal amounts of radioactivity for each of the cleavage products were analyzed by
electrophoresis through a 15% polyacrylamide-7 M urea
sequencing gel.
Northern (RNA) and Southern analyses. RNA from mouse
tissues was isolated by the guanidinium isothiocyanate
method (10). Poly(A)+ mRNA was purified on oligo(dT)
columns (Stratagene) according to the manufacturer's instructions. One microgram of mRNA was electrophoresed
through each lane of a 1.5% agarose gel and transferred to a
Nitropure membrane (MSI, Westboro, Mass.). Following
hybridization with the 1.4-kb insert from a partial CBF 1
cDNA clone (encompassing nucleotides 139 to 1463 of CBF
13 p21.5), the blot was washed with 2x SSPE-0.1% SDS at
RT and 0.1 x SSPE-0.1% SDS at elevated temperatures until
background was diminished as monitored with a Geiger
counter (approximately 650C).
Genomic DNA was isolated from mouse liver (55).
Twenty micrograms of genomic DNA was digested with
restriction endonucleases BamHI, EcoRI, HindIII, PstI,
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The digested DNA was fractionated

through a 0.7% agarose gel and transferred to a nylon
membrane (Nytran; Schleicher & Schuell). The membrane
was prehybridized in 50% formamide-6xSSC-10x Denhardt's solution-1.0% SDS-0.1 mg of salmon sperm DNA
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FIG. 1. Purification of bovine CBF polypeptides p24 and p19.
(A) Ponceau S-stained nitrocellulose membrane following transfer of
affinity purified bovine CBF from an SDS-polyacrylamide gel.
Lanes: 1, affinity-purified CBF; 2, low-molecular-weight protein
standards. The arrows indicate positions of the two CBF polypeptides (p24 and p19) that were excised and sequenced. Sizes are
indicated in kilodaltons. (B) Assay for core-binding activity of
renatured CBF p24 and p19 polypeptides recovered from a
Coomassie brilliant blue-stained SDS-polyacrylamide gel. Lanes: 1,
binding of CBF p24 to the HA probe; 2, binding of p24 to the HA
probe in the presence of a 500-fold molar excess of unlabeled HA
site; 3, competition of p24 binding to the HA probe by the WT core
site; 4, competition with the MUT site; 5, binding of CBF p19 to the
HA probe; 6, binding of p19 to the HA probe in the presence of
unlabeled HA; 7, competition of p19 by unlabeled WT; 8, competition of p19 with unlabeled MUT core site. The letters a and b
indicate two protein-DNA complexes obtained with proteins renatured from both the p24 and p19 polypeptide bands.
per ml and hybridized in 40% formamide-6x SSPE-1.0%
SDS-50 jig of salmon sperm DNA per ml-10% dextran
sulfate, using the insert from the 1.4-kb partial CBF 1 cDNA
42° C. The filters were
clone (1 106 to 2 x 106 cpm/ml) at
washed twice with 2x SSC-0.1% SDS at RT for 15min,
once with x SSC-0.1% SDS at RT, and once with 0.lx
for min.
15
at
SSC-0.1% SDS 50°C
Nucleotide sequence accession numbers. The GenBank accession numbers for the CBF 13 cDNA clones are as follows:
CBF 13 p21.5, L03279; CBF 1 p22.0, L03306; and CBF 1
pl7.6, L03305. The CBF 13 p22.0 sequence entered in GenBank begins at the putative ATG translation start codon.

0.5

RESULTS

Purification and amino acid sequence analysis of CBF. We
scaled up the purification of CBF, following the basic
purification scheme described previously (60). The affinitypurified CBF preparation was fractionated through an SDS15% polyacrylamide gel, and the proteins were transferred
onto a nitrocellulose membrane (2) (Fig. 1A). Only two
polypeptides migrating with apparent molecular sizes of 24
and 19 kDa (p24 and p19) were present in adequate amounts
and transferred to the nitrocellulose membrane with sufficient efficiency for microsequence analysis. We eluted and
renatured both proteins from a Coomassie brilliant bluestained polyacrylamide gel run in parallel and assayed the
renatured proteins to confirm that they had core-binding
activity (Fig. iB). Both renatured p24 and p19 bound to the
core site, and both yielded two protein-DNA complexes (a
and b) in electrophoretic mobility shift assays. We will
discuss the significance of these two protein-DNA complexes later.
Both p24 and p19 were excised from the nitrocellulose
membrane and digested with trypsin in situ, and the tryptic
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FIG. 2. Reverse-phase HPLC of tryptic peptides from CBF polypeptides p24 and p19. (A) Absorbance profile of tryptic peptides from p24
CBF at 210 nm. Numbered peaks correspond to sequenced peptides in Fig. 3. Note that peak 1 is the difference peak between p24 and p19.
(B) Absorbance profile of tryptic peptides from p19 CBF. mAU, milli-absorption units.

peptides were separated by high-pressure liquid chromatography (HPLC) (Fig. 2). The elution profiles of tryptic peptides from p24 (Fig. 2A) and p19 (Fig. 2B) were superimposable, except that p24 contained an extra peptide peak (peak
1; Fig. 2A). The peptides in peaks 1 to 5 in Fig. 2 were
sequenced (Fig. 3). Peak 4 contained two peptides and
yielded two sequences (4a and 4b). Three peptide sequences
from peaks 3 and 5 are combined into one sequence in Fig.
3 (peptide 3/5). Both the similar tryptic peptide elution
profiles and the fact that both p24 and p19 contain tryptic
peptides (in peaks 3 and 5) having the same amino acid
sequence indicate that the two proteins are highly related.
Four tryptic peptides from p24 and p19 show no sequence
homology to any proteins in computer data bases. However,

peptide 2 from p24 shares 70% sequence identity with the
protein encoded by the Drosophila segmentation gene runt
(30) and 100% homology to a protein encoded by the human
AMLI gene (39) (Fig. 3). runt is a pair rule gene and plays a
key role in regulating the expression of all other pair rule
genes (8, 9, 17, 21, 24). runt encodes a nuclear protein which
by sequence analysis does not contain either a recognizable
DNA-binding or dimerization domain (30). The AMLI gene
is located on chromosome 21 in humans, at the t(8;21)
translocation breakpoint frequently found in the leukemic
cells from patients with the M2 subtype of acute myeloid
leukemia (39). The function of the AML1 protein was not
reported (39). The proteins encoded by runt and AMLI are
homologous in a 118-amino-acid (aa) region that includes a
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FIG. 3. Sequences of CBF p24 and p19 tryptic peptides. Peptide numbers correspond to peaks in Fig. 2. The sequences of the three
peptides from peaks 3 and 5 are combined. Peak 5 from p19 contained two peptides. One peptide in peak 5 is an incomplete trypsin cleavage
product, containing a Gly-Arg in the first two positions. The sequences of the other peptide in peak 5 and the peptide in peak 3 from p24 are
identical and start at the third amino acid (Ser). An amino acid in brackets indicates an interpretation with reasonable confidence, and an
amino acid in parentheses indicates a low-confidence result. A hyphen indicates that no sequence determination could be made at that
position. The sequence of peptide 2 is compared with those of the corresponding amino acid sequences of the human AML1 and Drosophila
runt proteins below. The sequence of AML1 is from aa 91 to 113 (39), and the runt sequence corresponds to aa 146 to 168 (30). Amino acids
that are identical in runt and peptide 2 are underlined.

consensus ATP or GTP binding domain (13). Peptide 2 from
p24 is contained within this 118-aa runt/AMLl homologous
region. A tryptic peptide from p19 elutes at the same position
as does peptide 2 from p24 (Fig. 2), suggesting that the
runt/AMLJ homologous peptide is present in both p24 and
p19. However, the amino acid sequence of the analogous
peptide from p19 was not determined; therefore, we did not
conclusively demonstrate that the runt/AMLI homologous
peptide is present in the p19 polypeptide band.
Molecular cloning and sequence analysis of the CBF I
subunits. Two PCR primers deduced from the amino acid
sequence of peptide 3/5, which was the longest peptide with
the lowest degeneracy, were used to amplify the sequence
between the primers from template DNA prepared from a
mouse thymus cDNA library. Two 25-mers were designed
from the amplified 50-bp sequence and used as probes to
screen the mouse thymus cDNA library. One cDNA clone
that hybridized with both 25-mers was isolated from the
cDNA library and found to contain a 1.4-kb insert. Preliminary DNA sequence analysis indicated that this cDNA clone
encoded peptide 3/5 but lacked a complete 5' end. Therefore,
using the 1.4-kb insert as a probe, we isolated 11 additional
clones from the mouse thymus cDNA library. The complete
nucleotide sequence of one of these cDNA clones, CBF ,B
p21.5, is presented in Fig. 4A. The structures of all three
cDNA clones are diagrammed schematically in Fig. 4B, and
the deduced amino acid sequences of the three proteins are
presented in Fig. 4C.
The CBF 13 p21.5 cDNA clone contains a 2,742-bp insert
and a long open reading frame encoding a polypeptide of 182
aa with a calculated molecular weight (Mr) of 21,500 (Fig.
4A). The calculated molecular weight is in good agreement
with the molecular weights of the purified bovine CBF
polypeptides, p24 and p19. Coding sequences for two tryptic
peptides, 3/5 and 4a, are contained within the long open
reading frame. The coding sequence for tryptic peptide 1
from bovine p24, which was the difference peptide not
present in p19, is contained in CBF 13 p21.5 but is in the +1
reading frame relative to the coding sequences for peptides
3/5 and 4a. CBF 13 p21.5 contains a 1,997-nucleotide 3'
untranslated region, ending in a poly(A) tail. A consensus
polyadenylation sequence AATAAA is not found, but a

related sequence ATTAAA is located 13 nucleotides from
the poly(A) tail.
The nucleotide sequence of the cDNA clone CBF 1 p22.0
predicts a long open reading frame encoding a polypeptide of
187 aa (Mr = 22,000). The sequence of CBF 1 p22.0 contains
a 1,319-bp 5' untranslated region that starts with a stretch of
thymidines and contains a site for EcoRI restriction endonuclease cleavage at nucleotide 584 (data not shown). Since
the mouse thymus cDNA library was prepared by using
EcoRI linkers, we suspect that the insert contains two
unrelated cDNAs fused head to head. Sequences between
the 5' end of the insert and the EcoRI site at nucleotide 584
contain a 412-nucleotide-long open reading frame (in reverse
orientation), supporting the hypothesis that the 5' end of the
insert is derived from an unrelated cDNA. We cannot,
therefore, determine the bona fide 5' end of the CBF 1 p22.0
cDNA and have numbered the CBF 1 p22.0 sequence in Fig.
4B starting at the putative ATG translation start codon. The
3' untranslated sequence of CBF 13 p22.0 diverges from that
of CBF 1 p21.5 starting at nucleotide 1192 (corresponding to
nucleotide 1304 in CBF 13 p21.5) and contains 331 nucleotides of nonhomologous sequence.
Coding sequences for three tryptic peptides (peptides 1,
3/5, and 4a) are contained within the long open reading frame
of CBF 13 p22.0 (Fig. 4C). A 31-bp deletion near the 3' end of
the long open reading frame of CBF 13 p22.0 (relative to CBF
1 p21.5) brings the coding sequences for peptide 1 into the
same reading frame as the coding sequences for peptides 3/5
and 4a. This is consistent with the presence of peptide 1 in
the larger 24-kDa bovine protein. We identified three other
independent cDNA clones that had the same 31-bp deletion
and a total of eight that did not (data not shown). Thus, we
conclude that the 31-bp difference between CBF 13 p22.0 and
CBF 1 p21.5 results from alternative splicing and is not a
cloning artifact. The coding sequence of CBF 1 p21.5 at the
5' endpoint of the 31-bp deletion contains a characteristic
donor splice site (40) (Fig. 4B), suggesting that it serves as an
alternative splice donor to yield the CBF 13 p22.0 transcript.
Isolation and characterization of the genomic clone of CBF
13 will be necessary to confirm or disprove this hypothesis.
CBF 13 p17.6 encodes a 148-aa protein with an Mr of
17,600. CBF 1 p17.6 contains the same 31-bp deletion near
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FIG. 4. Nucleotide and amino acid sequences of CBF subunits. (A) Nucleotide sequence of CBF p21.5, with the deduced amino acid
(single-letter code) in the major long open reading frame. The putative ATG start codon is underlined. The sequences corresponding
to bovine peptides 3/5 and 4a are shown beneath the deduced amino acid sequence. Positions of amino acid sequence identity with the bovine
peptides are indicated by asterisks; positions of amino acid sequence divergence are indicated by the substituted amino acid. Positions of
sequences corresponding to peptide 1 (in the + 1 reading frame) are underlined and noted. The putative polyadenylation sequence (ATTAAA)
is also underlined. The boundaries of the 117- and 31-bp deletions in CBF p22.0 and CBF 13 p17.6 (nucleotides 248 to 364 and 577 to 607)
are indicated by brackets in the nucleotide sequence. The partial 1.4-kb cDNA clone that was first isolated contains sequences from
nucleotides 139 to 1463 of CBF p21.5. Putative casein kinase II (CKII), protein kinase C (PKC), and tyrosine (tyr) phosphorylation (phos.)
sites are noted. (B) Schematic diagram showing the relationship between the CBF p21.5, CBF p22.0, and CBF 1B p17.6 cDNA clones
(GenBank accession numbers L03279, L03306, and L03305, respectively). Only the overlapping regions of the cDNA clones are shown.
Numbers correspond to the nucleotide sequence of each cDNA clone as entered into GenBank. Since the 5' end of CBF p22.0 appears to
include sequences from another unrelated cDNA resulting from head-to-head fusion, we cannot determine the bona fide 5' end of the CBF
p22.0 cDNA. Therefore, we have numbered the CBF , p22.0 sequences starting at the putative ATG start codon. White rectangles indicate
long open reading frames. ATG and TAA or TAG translation start and stop codons are shown. Positions of the 31- and 117-bp deletions in
CBF p22.0 and CBF p17.6 are indicated by jagged lines. The nucleotide sequence including and immediately adjacent to the site of the
31-bp deletion found in both CBF p22.0 and CBF p17.6 is shown below the CBF p21.5 diagram. The 31 nucleotides that are deleted
are boxed. Asterisks indicate the residues at the 5' deletion endpoint that are conserved in typical splice donor sequences (40). (C) Deduced
amino acid sequences of the proteins encoded by the CBF cDNA clones. Numbers correspond to the CBF p22.0 amino acid sequence.
Amino acids corresponding to the bovine tryptic peptides are underlined.
sequence

the 3' end of the open reading frame found in CBF ,B p22.0
and an additional 117-bp deletion near the middle of the open
reading frame (Fig. 4B). This 117-bp deletion removes coding sequences for most of peptide 3/5 and all of peptide 4a

(Fig. 4C). CBF 1B p17.6 was the only cDNA that we isolated
which contains this deletion, and thus the deletion could be
an artifact of cloning. The 3' untranslated region of CBF
p17.6 is identical to that of CBF p21.5.
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FIG. 4-Continued.

Although not shown in Fig. 4A, the long open reading
frame of CBF , p21.5 (and CBF p17.6) continues to the 5'
end of the insert. We have tentatively designated the ATG at
position 82 in CBF p21.5 as the initiation codon, based on
the sequence of the CBF p p22.0 cDNA clone, in which the
open reading frame ends 696 nucleotides 5' to this ATG (3' to
the internal EcoRI site) and does not contain another ATG.
The putative ATG initiation codon is in the context of an
imperfect Kozak consensus sequence for translational initiation, in that a C at the +4 position is not favorable
(AAGATGC) (32).
The proteins encoded by the CBF cDNA clones do not
contain any DNA-binding motifs commonly found in DNAbinding proteins (for a review, see reference 26), nor is there
a predominantly basic region in the protein suggestive of a
DNA-binding domain. There are also no acidic, glutaminerich, or proline-rich regions that are characteristic of activation domains. The CBF p proteins do not contain the
prototypic nuclear targeting sequence first found in the
simian virus 40 large T antigen (28); however, a potential
bipartite nuclear targeting sequence is present at aa 19 to 35
(RKLSRECEIKYTGFRDR) (46). Both the protein and nucleotide sequences of CBF p p22.0 were used to search
computer data bases for other related sequences (3). No
significant homology to any other protein was revealed in the
search.
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The coding sequence for peptide 2, which is the runt!
AML1 homologous peptide, is not contained within any of
the CBF ,B cDNA clones. Therefore, at least two proteins
migrated in the SDS-polyacrylamide gel from which the
bovine proteins were purified with an apparent molecular
size of 24 kDa (and probably also 19 kDa) and were excised
from what had appeared to be a single band. The two
proteins generated a mixture of tryptic peptides. One protein
is encoded by the CBF 0i gene, and it contributed peptides 1,
3/5, and 4a. We believe that the protein that comigrated with
the CBF p-encoded protein is the bovine homolog of human
AMLI, and it contributed peptide 2. We could not find
coding sequences for the short peptide 4b either in the mouse
CBF fi cDNA clones or in the published human AML1
sequence (39).
The CBF fi subunits form a complex with DNA-binding
CBF a subunits. We subcloned the open reading frames of
CBF ,B p22.0, CBF c p21.5, and CBF c p17.6 into the GST
vector pGEX2T and expressed the CBF c proteins as GST
fusion proteins. The GST fusion proteins were purified on
glutathione-agarose beads, and fractions of the eluate were
analyzed by SDS-polyacrylamide gel electrophoresis
(PAGE) (data not shown). The fusion proteins migrated with
apparent molecular sizes of 49 kDa (CBF ,B p22.0-GST), 47
kDa (CBF c p21.5-GST), and 44.5 kDa (CBF c p17.6-GST),
consistent with their predicted molecular sizes plus that of
the 27-kDa GST domain.
We tested whether the CBF P-GST fusion proteins would
bind to the core site but could detect no protein-DNA
complexes by electrophoretic mobility shift assay. We then
examined whether the CBF c proteins are part of a protein
complex that binds to the core site and purified the DNAbinding component of CBF from affinity-purified bovine
CBF to test this hypothesis. Bovine CBF was fractionated
through an SDS-polyacrylamide gel, the gel was stained with
Coomassie brilliant blue, and each visible protein band was
excised from the gel (Fig. 5A). Proteins were eluted from
each gel slice (A to N), renatured, and tested for corebinding activity (Fig. 5B).
As shown previously, each protein in the molecular size
range of 17 to 33 kDa binds to the core site (60). Several
proteins (B to E and N) give rise to one protein-DNA
complex. Proteins migrating in the molecular size range of 19
to 27 kDa (F to M) yield two protein-DNA complexes. We
noted this phenomenon previously and at that time hypothesized that the second protein-DNA complex with lower
mobility contains two CBF subunits bound to the probe (60).
As we will demonstrate later, we now believe that the
fast-mobility protein-DNA complex contains only a DNAbinding subunit of CBF (which we call CBF a subunits) and
that the lower-mobility protein-DNA complex contains both
a DNA-binding subunit of CBF (CBF a) and a non-DNAbinding subunit of CBF (CBF ,B). The large molecular size
range of the CBF a subunits appears to be contributed by a
combination of proteolysis and splicing variants (4, 12, 25,
39). The hypothesis that the CBF c cDNA clones that we
isolated encode non-DNA-binding subunits of CBF is consistent with the 19- to 27-kDa molecular size range in which
the bovine proteins that yield two protein-DNA complexes
migrate, which corresponds to the predicted size of several
of the CBF P subunits. A range of 19 to 27 kDa is also
reasonably consistent with the size range of the core-binding
PEBP2 P subunits (20 to 24 kDa) purified by Kamachi et al.
from c-Harvey-ras-transformed mouse fibroblasts (29).
Therefore, we reasoned that (i) gel slices that give rise to one
protein-DNA complex (B to E and N) contain only a
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To test the hypothesis that proteins encoded by the CBF ,B
cDNA clones are the non-DNA-binding subunits of CBF, we
tested the ability of the CBF 1-GST fusion proteins to shift
the mobility of protein-DNA complexes formed with bovine
CBF a- subunits (polypeptides B to E and N in Fig. 5). CBF
13 p22.0-GST, CBF 1 p21.5-GST, and CBF 13 p17.6-GST
alone do not bind to the core site (Fig. 6A, lanes 6, 11, and
15). However, when included in binding reactions with
renatured bovine CBF a subunits, both CBF 1 p22.0-GST
and CBF 13 p21.5-GST decrease the mobility of the proteinDNA complex. An approximately 10:1 molar ratio of CBF 1
to CBF a drives 50% of the CBF protein-DNA complex into
the ot+ 1 form (lanes 3 and 8). We found that all of the
renatured bovine CBF a polypeptides (B to E and N)
associate with the CBF 13 p22.0-GST and CBF 13 p2l.5-GST
subunits (data for all CBF a subunits not shown). Furthermore, we find that when CBF 1 p22.0-GST and CBF 13
p21.5-GST are combined with CBF ao polypeptides that yield
two protein-DNA complexes (F to M), the higher-mobility
CBF at protein-DNA complex is driven into a lower-mobility
form (data not shown). The CBF 13 subunits do not, however, associate with an unrelated protein Ets-1 to form a

I-'

B
A

B

F'

D

G

1

-I

J

L

K

M

N

lower-mobility protein-DNA complex (18).
CBF 13 p17.6-GST cannot participate in the formation of a
protein-DNA complex with CBF a subunits (Fig. 6A, lanes
12 to 14). We determined whether CBF 13 p17.6 can interfere
with the association of the CBF 1 p22.0 and CBF 13 p21.5
subunits with CBF ao subunits. If, for example, the associa-

tion of CBF 13 subunits to the CBF a subunit was dependent
dimerization, then CBF 13 p17.6 could potentially
dimerize with CBF 13 p22.0 and CBF 13 p21.5 and inhibit their
association to the CBF ao subunit. Mixing experiments were
performed in which a 1:1 or 10:1 molar ratio of CBF 1
p17.6-GST to either CBF 1 p21.5-GST or CBF 1 p22.0-GST
was added to binding reactions containing CBF ae subunits
(Fig. 6B). CBF 1 p17.6-GST did not interfere with the
association of CBF 13 p21.5 or CBF 13 p22.0 to the CBF ao
protein-DNA complex even when present in a 10-fold molar
excess. One caution in interpreting this result, however, is
that CBF 13 dimers may exchange subunits too slowly for
significant exchange to occur during the binding reaction.
Association of CBF 13 subunits stabilizes DNA binding by
CBF a subunits. DNase I footprinting analyses were performed to determine whether the association of CBF 13
subunits qualitatively alters the footprint generated by the
CBF ao subunits. We found, however, that CBF ao by itself
does not generate a footprint on the core sites in the TCRy
enhancer (Fig. 7). Increasing the amount of CBF a- in the
binding reactions resulted in either nonspecific binding or
repression of DNase I cleavage (Fig. 7A, lane 4). Upon
addition of either CBF 13 p22.0-GST or CBF 13 p21.5-GST
(but not CBF 13 p17.6-GST or GST alone), a clear footprint
appears over the two core sites in the TCR-y enhancer.
Association of the CBF 13 subunits therefore appears to
increase the stability of the CBF protein-DNA complex.
The observation that CBF a binding can be detected by
electrophoretic mobility shift but not by DNase I footprinting assays suggests that CBF ao dissociates from the DNA
during the 1-min incubation with DNase I. To determine
whether this is indeed the case and whether the association
of CBF 13 decreases the rate of dissociation, we measured
the dissociation rates of the CBF ao protein-DNA complex
and the CBF a+ 1 protein-DNA complex by electrophoretic
mobility shift assays (Fig. 8). The dissociation of both CBF
a alone and CBF a+ 1 (CBF 13 p21.5) from the HA probe was
too rapid to measure when both the binding reactions and

on CBF 13
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FIG. 5. Recovery of DNA-binding bovine CBF a subunits from
SDS-polyacrylamide gels. (A) Fractionation of polypeptides by
SDS-PAGE. Shown is the Coomassie brilliant blue-stained SDSpolyacrylamide gel from which the different polypeptides were
excised. The CBF preparation is the same as that used to obtain
purified bovine p24 and p19. Five hundred microliters of the
affinity-purified fraction was trichloroacetic acid precipitated and
electrophoresed through an SDS-15% polyacrylamide gel, and the
gel was stained with Coomassie brilliant blue. Lanes: 1, affinitypurified CBF; 2, low-molecular-weight protein standards (positions
indicated in kilodaltons). Arrows indicate the bands that were
excised from the Coomassie brilliant blue-stained SDS-polyacrylamide gel. The CBF polypeptide bands are labeled sequentially by
letters from top to bottom (A to N). Polypeptides G and K are p24
and p19, respectively. (B) Electrophoretic mobility shift assay of
core-binding activity from renatured polypeptides. The excised
polypeptides were eluted from the SDS-gel slices and subjected to a
denaturation/renaturation regimen as described previously (19, 60).
Ten microliters of each renatured protein was assayed for corebinding activity, using 20,000 cpm of the HA probe. The letter above
each lane corresponds to the letter of the polypeptide band in panel
A. Lane 1 contains 2 ,ul of the affinity-purified CBF sample prior to
fractionation by SDS-PAGE.

DNA-binding subunit of CBF (CBF a), (ii) gel slices that
give rise to two protein-DNA complexes (F to M) contain
both a DNA-binding CBF ao subunit and a CBF subunit,
and (iii) protein-DNA complexes containing both CBF at and
CBF subunits migrate more slowly on native polyacrylamide gels than do protein-DNA complexes containing CBF
a

subunits alone.
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FIG. 6. Association of CBF p-GST fusion proteins with DNA-binding CBF a subunits. (A) Various amounts of CBF P-GST fusion
proteins were added to 4 p.1 (approximately 1 to 5 ng; 2 x 10-' M to 6 x 10-' M, final concentration) of the CBF a subunit recovered from
the SDS-polyacrylamide gel (polypeptide C from Fig. 5), and binding was measured by electrophoretic mobility shift assay using the HA
probe. Lanes: 1, binding of the CBF a subunit alone; 2 to 5, CBF a plus 5 ng, 50 ng, 500 ng, and 2.5 ,ug of CBF 13 p22.0-GST; 6, 2.5 ,ug of
CBF p22.0-GST alone; 7 to 10, CBF a plus 5 ng, 50 ng, 500 ng, and 5 pug of CBF p21.5-GST; 11, 5 ,ug of CBF ,B p21.5-GST alone; 12 to
14, CBF a plus 10 ng, 100 ng, and 1 ,ug of CBF p17.6-GST; 15, 1 pLg of CBF ,B p17.6-GST alone. FP shows the position of the free probe;
a and a+p indicate positions of the protein-DNA complexes formed with the CBF a subunit in the absence and presence of the CBF ,B-GST
fusion proteins, respectively. (B) CBF p17.6 does not inhibit association of CBF p21.5 and CBF 13 p22.0 to the CBF a protein-DNA
complex. Lanes: 1, binding of 500 ng of GST alone; 2, 500 ng of CBF p22.0-GST; 3, 500 ng of CBF p21.5-GST; 4, 500 ng of CBF
p17.6-GST; 5, binding of 2.5 p,l (estimated to be <1 to 5 ng) of renatured bovine CBF a subunit alone (polypeptide C from Fig. 5); 6 and 7,
CBF a plus 50 and 500 ng of GST; 8 and 9, CBF a plus 50 and 500 ng of CBF p22.0-GST; 10 and 11, CBF a plus 50 and 500 ng of CBF
p21.5-GST; 12 and 13, CBF a plus 50 and 500 ng of CBF p17.6-GST; 14 and 15, competition of CBF a binding by 20 ng (200-fold molar
excess) of the unlabeled HA and MUT sites; 16 and 17, competition of CBF a plus 500 ng of CBF p22.0-GST with HA and MUT sites; 18
and 19, competition of CBF a plus 500 ng of CBF p21.5 with HA and MUT sites; 20, CBF a plus 50 ng of CBF p22.0-GST and 50 ng of
GST; 21, CBF a plus 50 ng of CBF p22.0-GST and 500 ng of GST; 22 and 23, CBF a plus 50 ng of CBF p22.0-GST and 50 (lane 22) and
500 (lane 23) ng of CBF p17.6-GST; 24 and 25, CBF a plus 50 ng of CBF p21.5-GST and 50 (lane 24) and 500 (lane 25) ng of GST; 26 and
27, CBF a plus 50 ng of CBF p21.5-GST and 50 (lane 26) and 500 (lane 27) ng of CBF p17.6-GST. a and a+ represent the protein-DNA
complexes formed with the CBF a subunit in the absence and presence of the CBF 1-GST fusion proteins, respectively.
3

electrophoresis were conducted at RT (data not shown).
When the competition was performed at 0°C and the binding
reactions were electrophoresed at 4°C, the CBF at proteinDNA complex still dissociated rapidly but at a rate that
could be measured experimentally by electrophoretic mobility shift assay (Fig. 8A, lanes 1 to 5). Addition of CBF L
p21.5-GST to the binding reactions significantly decreased
the rate of dissociation of the CBF protein-DNA complex
(Fig. 8A, lanes 6 to 10). We plotted the data as shown in Fig.
8B and from this calculated a dissociation rate constant for
the CBF a protein-DNA complex of 8.8 x 10-2 s-1 and for
the CBF a+1 protein-DNA complex (13 = CBF p21.5GST) of 1.25 x 10-2 s - at 0°C, corresponding to a sevenfold
decrease in the dissociation rate constant upon association
of CBF 13.
We also determined the dissociation rate constants for the
two protein-DNA complexes generated from the bovine
CBF proteins eluted from gel slices F to M in Fig. 5 (Fig. 8A,
lanes 11 to 15; Fig. 8C). The faster-migrating complex which

only CBF a subunits dissociated
of CBF a alone (7.0 x 10-2 s-1).
The protein-DNA complex that migrates more slowly and
presumably contains both CBF a and CBF
subunits
dissociates more slowly, with a rate constant of 1.6 x 10-2
s-1, supporting the hypothesis that it contains both a DNAbinding at and non-DNA-binding subunit.
Association of the CBF 13 subunit does not extend the
we hypothesized contained
at a rate comparable to that

4

5

6

8

12

25 26

phosphate contacts made by CBF in the core site. To determine whether the association of CBF changes the contacts
made by the CBF a subunit, we compared the phosphate
contacts made by CBF at in the absence and presence of the
CBF subunit. The ethylation interference analysis was
performed by using the bE3 core site from the TCRB
enhancer (45). CBF a contacts six phosphates on the top
strand and four phosphates on the bottom strand of the BE3
core site (lanes 3 to 5 in Fig. 9A and B). This finding is
consistent with the pattern of phosphate contacts made by
affinity-purified bovine CBF on the core site in the Moloney
MLV enhancer (37). This pattern of phosphate contacts is
not extended upon association of the CBF (CBF p21.5GST) subunit (lanes 6 to 8 in Fig. 9A and B); on the contrary,
there is some suggestion that the effect of ethylation at some
phosphates on the bottom strand is slightly less severe upon
association of the CBF subunit (Fig. 9C). This result
suggests that the dissociation rate constant of the CBF
protein-DNA complex is not decreased through the establishment of additional contacts between the protein and the
DNA upon association of CBF
Southern and Northern analyses of the gene for the CBF 13
subunits. The insert from the partial CBF p21.5 cDNA
clone (nucleotides 139 to 1463 of CBF p21.5) was used as
a probe in Southern blot analysis under stringent hybridization conditions (Fig. 10A). Multiple bands were observed
with use of a variety of restriction endonucleases, suggesting
13.
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FIG. 7. DNase I

footprint analysis
TCR-y gene in

the enhancer from the
fusion

proteins. (A) Binding

of CBF

ax subunit binding

the presence of CBF

to the core sites on the

top strand

to

13-GST
of the

sequencing
ladders; 3, BSA; 4, 25 pAl of CBF a (polypeptide D from Fig. 5); 5,
10 i±l of CBF a plus 2.5 p.g of CBF
p22.0-GST; 6, 10 p.l of CBF a
p2l.5-GST; 7, 10 of CBF a plus 2.5 p.g of
plus 2.5 p.g of CBF
CBF
p17.6-GST; 8, 10 pt1 of CBF a plus 2.5 p.g of GST; 9, BSA.
Boxes at the left indicate positions of the two core motifs (CTGTG
GTTT and CTGTGGTCT) in the TCR-y enhancer. (B) Binding of

TCRoy

enhancer. Lanes: 1 and 2, G and G+A chemical
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species
species
a
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expression

mRNA

contains

enhancer.

of related genes.

thymus
mRNA

TCR-y

panel A except that lane 4 contains
polypeptide 5C was used in footprint-

those in

kb,

a

less abundant

thymus migrates at 2.5 kb, and muscle
mRNA species not found in other

2.8-kb CBF

Differences in the level of CBF

P mRNA levels

(thy(thymus/testis), with an average
difference of 11-fold. When normalized by densitometry to
the actin signal, the differences in mRNA levels range from
0.9-fold (thymus/liver) to 6.6-fold (thymus/spleen).
thymus
mus/muscle) to

between

and other tissues range from 2.6-fold

29-fold

DISCUSSION

We

have isolated and sequenced three cDNA clones from
thymus encoding non-DNA-binding subunits of the

mouse

transcription factor CBF. The nucleotide sequences of the
three cDNA clones are 100% identical over approximately
1,200 bp (excluding the 117- and 31-bp deletions), indicating
that the three proteins encoded by these cDNAs are translated from differentially spliced mRNAs transcribed from a
single gene. Two of the proteins encoded by the CBF 1
cDNA clones, CBF 1 p22.0 and CBF 1 p21.5, participate in
the formation of a protein-DNA complex with a DNAbinding CBF ot subunit. We have thus far detected no
difference in the DNA-binding properties of protein-DNA
complexes containing the CBF 1B p22.0 and CBF 1 p21.5
subunits, although we have not rigorously compared their
equilibrium or kinetic binding constants. The differences in
the carboxyl termini of CBF 1 p21.5 and CBF ,B p22.0 may
affect other biochemical properties of the proteins, such as
their ability or efficiency in activating transcription from the
promoter or their interactions with proteins binding to adjacent sites on enhancers.
The protein encoded by the third cDNA clone, CBF 1
p17.6, does not form a complex with CBF ao, nor does it
inhibit the association of the CBF L p22.0 or CBF 13 p21.5
subunits to the CBF ao protein-DNA complex. CBF ,B p17.6
may, however, interfere with other biochemical processes,
perhaps through squelching of essential components of the
transcriptional apparatus.
The association of CBF 13 p21.5 decreases the rate constant of dissociation of the CBF protein-DNA complex. This
decrease in the dissociation rate constant is not accompanied
by an extension of the phosphate contacts in the binding site,
as evidenced by the similarity of the phosphate interference
patterns generated by the CBF a subunit alone and the CBF
ao+1 complex. Two models are compatible with the observations that CBF 1B stabilizes the protein-DNA complex yet
does not extend the phosphate contacts on the DNA. One
model is that CBF ,B stabilizes a conformation assumed by
CBF a that is favorable for binding but that CBF 13 does not
itself contact DNA directly. This model presupposes that
CBF at binds as a monomer, and therefore that the association of CBF 13 does not involve exchange of a DNA-binding
CBF a subunit. An alternative model is that CBF 13 does
displace a subunit of CBF ao and contacts the DNA directly
but that the CBF ao+1 heterodimer establishes essentially
the same contacts as CBF a alone.
We predict that CBF ac binds as a monomer, that the
association of CBF 13 to CBF a does not involve a subunit
exchange, and therefore that the first model (CBF L stabilizes a conformation assumed by CBF a) is correct. The
reasons for our prediction are as follows. (i) Association of
CBF 1 to the protein-DNA complex decreases the mobility
of the protein-DNA complex relative to CBF al alone,
suggesting that rather than displacing a subunit, CBF 1
piggybacks onto the complex. For example, in Fig. 5, when
proteins from individual polypeptide bands excised from an
SDS-polyacrylamide gel which contain both CBF ao and CBF
13 subunits of identical molecular weights are assayed for
binding, the association of CBF L decreases the mobility of
the protein-DNA complex. If CBF 13 were instead displacing
one subunit of a homodimeric CBF ao complex, the mobility
of the protein-DNA complex should not change significantly.
(ii) Results from selected and amplified binding sequence
footprinting (6) indicate that the binding site selected by the
CBF a subunit alone is asymmetrical (PyGPyGGTPy), suggesting that it binds as a monomer (37, 38). Furthermore, the
distributions of binding sites selected by CBF ao and CBF
a+ 1 subunits are indistinguishable; thus, association of the
CBF ,B subunit does not appear to alter sequence specificity
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(A) Binding reactions were performed at RT for 20 min and then equilibrated on
competitor was added to trap the dissociated protein, and 15-p.l aliquots were removed at the
indicated time points and loaded onto a running gel (equilibrated at 40C). Lanes: 1 to 5, CBF aL (polypeptide B) at t
0, 15, 30, 60, and 300
s; 6 to 10, CBF a plus CBF p2l.5-GST at t
0, 15, 30, 60, and 300 s; 11 to 15, bovine CBF a+
0, 15, 30, 60,
(polypeptide band J) at t
and 300 s. The mobility of the CBF a+
protein-DNA complex in lanes 6 to 10 is lower than that in lanes 11 to 15, presumably because of
the added molecular weight of the GST domain in the CBF 13-GST fusion protein. (B and C) Plots of log(% bound at each time [relative to
t
01
% bound at t
oo) versus time (seconds) for the bovine CBF at protein-DNA complex (data from lanes 1 to 5) and bovine CBF a
plus CBF
p2l.5-GST protein-DNA complex (data from lanes 6 to 10) (B) and for bovine CBF a and bovine CBF a+13 protein-DNA
complexes from polypeptide band J (data from lanes 11 to 15) (C).
FIG. 8. Measurement of rate constant for dissociation.

ice for 15

min.

A 50-fold molar

excess

of HA

=

=

=

(38).

=

=

We therefore favor the

a monomer

and that CBF

hypothesis

that CBF

ax

does not contact DNA

binds

as

directly.

CBF is a new member of a relatively small group of
transcription factor complexes shown to be composed of a
DNA-binding subunit(s) associated with a non-DNA-binding
subunit, in which the non-DNA-binding subunit increases
the affinity of the protein complex for the binding site.
Another member of this group is the transcription factor
AP-1, which consists of a DNA-binding subunit, Jun, in a
heteromeric complex with a Fos subunit (Fos-Fos homodimers cannot bind DNA). DNA-binding Jun-Jun homodimers dissociate from the DNA at
Fos-Jun heterodimers

(43).

Fos-Jun heterodimer is

a

faster rate than do

DNA-binding domain of the
contributed by both Fos and Jun, and
The

both

proteins have been demonstrated to contact the DNA
directly (1). Jun-Jun homodimers and Jun-Fos heterodimers
make the same contacts on the DNA (as assayed by DNase
I footprinting) (1), although phasing analysis demonstrated
that Jun-Jun and Fos-Jun bend DNA in opposite directions
(31). We predict that the mode of DNA binding by CBF is
significantly different from that of Fos and Jun because we
believe that the association of CBF

involve

subunit

to

CBF

a

does not

exchange.
Another example of a protein complex consisting of DNAbinding and non-DNA-binding subunits is the yeast transcription factor complex HAP21314. HAP2/3/4 consists of
three nonidentical subunits, all of which are required for
a

binding and transcriptional activity (16, 41). The
DNA-binding component of the complex is believed to be
contributed by the HAP2 and HAP3 proteins, and the
transactivation function is provided predominantly by HAP4
(41). However, CBF at can bind DNA by itself, whereas no
detectable DNA binding of the DNA-binding subunits
HAP2/3 occurs in the absence of HAP4 (16).
A third example of a transcription factor associated with a
non-DNA-binding subunit is the COUP (chicken ovalbumin
upstream promoter) protein, which is a member of the
steroid hormone receptor superfamily. The binding of COUP
to its recognition site is stabilized by the association of a
non-DNA-binding factor S300-II (58). Ethylation and methylation interference analysis detected no alterations in the
contacts made by COUP and COUP plus S300-II on the
DNA (58). S300-II was recently cloned and found to be
identical to the basal transcription factor TFIIB (23), raising
the possibility that CBF
could also be a general transcripDNA

tion factor.

sequenced five tryptic peptides from the bovine CBF
p19 proteins, only three of which are encoded by the
CBF
cDNA clones. One of the remaining peptides (peptide
2) is from the bovine homolog of a protein encoded by the
We

p24

and

human AMLJ

proto-oncogene. We believe that the AMLJ

gene encodes

a

pothesis
proteins

stems

DNA-binding

a

subunit of CBF. This

hy(i) The bovine
core-binding activity

from several observations.

renatured from

gel

slices had
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FIG. 9. Ethylation interference. (A) Ethylation interference of CBF on the top strand of the 8E3 site (45) from the TCRB enhancer. Lanes:
1, G+A chemical sequencing tract; 2, T+C; 3, CBF a protein-DNA complex from the mobility shift gel; 4, free DNA band from the CBF a
lane on the mobility shift gel; 5, free DNA; 6, CBF plus CBF a p21.5-GST protein-DNA complex from the mobility shift gel; 7, free DNA
band from the CBF a-plus-CBF p21.5-GST lane on the mobility shift gel; 8, free DNA. Vertical rectangles indicate the location of the core
site (TGTGGTT). (B) Ethylation interference of CBF on the bottom strand of the BE3 site from the TCRB enhancer. Lanes correspond to
those in panel A. (C) Analysis of ethylation interference results. On the top are densitometric analyses of autoradiographs. The graphs show
traces of the autoradiographic densities of the region immediately surrounding the BE3 site from the top and bottom strands of the probe, as
indicated. The top graphs compare the tracing of the CBF al protein-DNA complex (lanes 3 from panels A and B) with the tracing from the
free probe (lanes 5 from panels A and B). The bottom graphs compare the tracing from the CBF a protein-DNA complex (lanes 3 from panels
A and B) with the tracing from the CBF a-CBF ,1 p21.5-GST protein-DNA complex (lanes 6 from panels A and B). Thex coordinate is named
by the nucleotide whose 5' phosphate is ethylated. A summary of the ethylation interference results is illustrated on the bottom. The
phosphate contacts are shown by arrows above and below the sequence.
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FIG. 10. Southern and Northern

sis. Lanes:

PvuII-digested DNA; 7, ScaI-digested DNA; 8, XbaI-digested
DNA; 9 to 11, 2, 5, and 10 copies of the 1.4-kb partial CBF p21.5
cDNA clone (encompassing nucleotides 139 to 1463 of CBF
p21.5). Molecular weight markers are shown on the left in kilobases.
(B) Northern analysis of Poly(A)+ RNA hybridized with the 1.4-kb
insert from the partial CBF
p21.5 cDNA clone. The tissue source
of the mRNA is indicated above each lane. Molecular weight
markers are shown on the left in kilobases. Positions of the 3.1-,
2.8-, and 2.5-kb bands are noted. The gel at the bottom shows a
smaller region of the same blot probed for actin.
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and thus contained a DNA-binding a subunit. The DNAbinding subunit must be present in the p24 and p19 bands in
a stoichiometric ratio of at least 1:10 relative to CBF 13, since
the proteins eluted from the p24 and p19 bands yielded an
equal distribution of a, and ot+,1 protein-DNA complexes,
and we know from other experiments that an approximately
10-fold molar excess of CBF 1 will drive 50% of the a
protein-DNA complexes into the a+ 1 form. The molar ratio
of the AMLJ/runt homologous peptide 2 relative to peptides
1 and 3 from p24 was approximately 1:5, reasonably consistent with the expected stoichiometric ratio. A tryptic peptide
from the mixture of proteins that migrated at 19 kDa had the
same retention time on the HPLC column as did peptide 2
from p24 and is thus also likely to be the same AML1/runt
homologous peptide. The AML1 gene gives rise to multiply
spliced transcripts which could encode proteins of different
sizes (4, 12, 39). This could explain why the peptide encoded
by the AML1 gene might be present in proteins migrating at
two different molecular sizes (24 and 19 kDa). The observation that the p24 and p19 CBF 1 proteins were the predominant proteins in the affinity-purified CBF preparation could
result from relatively few CBF 13 subunits being associated
with a much larger number of CBF a subunits, each of which
is present in the affinity-purified preparation in smaller
amounts. (ii) AML1 and CBF 1 remained associated through
multiple purification steps, including a core site affinity
column. This finding suggests that AML1 and the CBF 1
subunits are tightly associated, that the copurification of
CBF 13 and AML1 was not merely coincidental, and that
both proteins are part of the protein complex that binds the
core site. (iii) AML1 is 92% homologous to another corebinding ao subunit, the PEBP2 a subunit, through the 118amino-acid region that is also conserved between the human
AMLl- and the Drosophila runt-encoded proteins and contains the peptide 2 sequence (25). PEBP2 was purified from
c-Harvey-ras-transformed mouse fibroblasts on the basis of
its ability to bind two core sequences in the polyomavirus
enhancer (TGTGGTlTl and TGCGGTC) (29). As with CBF,
purified preparations of PEBP2 were shown to contain
multiple polypeptides consisting of DNA-binding a subunits
and non-DNA-binding 1 subunits (25, 29). The PEBP2 13
subunits are identical to CBF 13 (25).
Since the AMLJ/runt homologous peptide 2 is from a
bovine protein and the AMLI and PEBP2 ax cDNA clones
were isolated from human and mouse cells, respectively,
there was some question of whether peptide 2 is derived
from the bovine homolog of AMLI or PEBP2 a. We PCR
amplified and sequenced a 220-bp sequence from mouse
thymus cDNA, using degenerate primers chosen from within
the 118-aa region that is conserved in the Drosophila runt
and human AML1 proteins (data not shown). The PCRamplified sequence from mouse cDNA encodes 75 aa that
are 100% identical to the human AML1 protein and are
therefore 100% homologous to the bovine peptide 2 sequence. Mouse PEBP2 a, on the other hand, contains two
conservative amino acid substitutions within the 23-aa peptide 2 sequence (25). Since we were able to identify a mouse
AMLl homolog that is 100% identical to human AMLJ in the
region encompassed by peptide 2, we believe that peptide 2
is derived from the bovine homolog of AMLL. While this
report was under review, Bae et al. (4) published the
nucleotide sequence of a cDNA derived from the murine
homolog of human AMLI and claim that it is encoded by a
gene distinct from murine PEBP2a. We predict that at least
one of the proteins encoded by the AMLI gene will bind the
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core site and will therefore represent one of the DNAbinding ot subunits of CBF.
CBF 1 mRNA was detected in a broad range of mouse
tissues, although levels were somewhat higher in thymus. In
contrast, only nuclear extracts prepared from thymus and
spleen contained core-binding activity (56, 59). Lung nuclear
extracts, for example, which contain relatively high levels of
CBF 1 mRNA, had no demonstrable core-binding activity.
The tissue distribution of core-binding activity, however, is
presumably determined by the expression of both the CBF a
and 13 subunits. PEBP2 at is highly expressed in thymus (25).
The tissue distribution of AML1 was reported to be widely
expressed (4, 39). The fact that CBF 1 is expressed in tissues
other than thymus and spleen also raises the possibility that
CBF 1 has other interaction partners besides PEBP2 t and
AML1.
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ADDENDUM IN PROOF
While this article was being revised, we learned that the
work cited in reference 25 will be described elsewhere (E.
Ogawa, M. Inuzuka, M. Maruyama, M. Satake, M. NaitoFujimoto, Y. Ito, and K. Shigesada, Virology, in press; E.
Ogawa, M. Maruyama, H. Kagoshima, M. Inuzuka, J. Lu,
M. Satake, K. Shigesada, and Y. Ito, Proc. Natl. Acad. Sci.
USA, in press).
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